Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD

• Main Authors: Jayne E. Hastedt (Author), Per Bäckman (Author), Andrew R. Clark (Author), William Doub (Author), Anthony Hickey (Author), Guenther Hochhaus (Author), Phil J. Kuehl (Author), Claus-Michael Lehr (Author), Peter Mauser (Author), Jason McConville (Author), Ralph Niven (Author), Masahiro Sakagimi (Author), Jeffry G. Weers (Author)
• Format: Book
• Published: SpringerOpen, 2016-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The Biopharmaceutics Classification System (BCS), developed in the 1990s for oral immediate release drugs, is utilized by R&D scientists and regulators to streamline product development and regulatory approval timelines. This elegant, science-based approach is based on three in vitro pa...